Trends, Challenges, and Considerations Shaping Biomarker Development and Precision Medicine in 2026 and Beyond The integration of artificial intelligence (AI) and multi-omics technologies is reshaping translational research, offering new approaches to drug discovery and precision medicine. In this dynamic landscape, biotech and pharmaceutical organizations are faced with the question of how to maximize the value of their investments in these tools while avoiding, or at least minimizing, costly m